Topical Reports on Different Pharma Companies R&D Focus by Global Markets Direct Now Available at MarketPublishers.com

17 Oct 2014 • by Natalie Aster

LONDON - Market Publishers Ltd announces that topical reports on various pharma companies’ R&D focus have been added to its catalogue.

Beijing Minhai Biotechnology Co., Ltd - Product Pipeline Review - 2014.  The study provides comprehensive and unbiased information on the company’s current therapeutic developmental pipeline, supplemented with a comparative analysis at different stages, therapeutics assessment by drug target, route of administration, mechanism of action and molecule type. It also looks at the most recent updates, featured news and press releases, and gives details about deals with respect to the company’s pipeline products, alongside features on late phase and discontinued projects …

Debiopharm International S.A. - Product Pipeline Review - 2014. The report assesses Debiopharm International S.A.’s strategic position with total access to detailed information on its product pipeline. It evaluates the prospects of the firm in its therapy focus areas, unveils novel drug targets and therapeutic drug classes in the company’s R&D portfolio, identifies windows of opportunity in the area, and discusses emerging market participants with a potentially strong portfolio of products. It reviews the company’s dormant and discontinued projects, which helps in discovering potential growth opportunities in the areas …

Histocell S.L. - Product Pipeline Review – 2014. The research publication provides a brief review of Histocell S.L., including the description of its business, essential information and facts, and its subsidiaries and locations. The reviews its existing pipeline of the company’s human therapeutic department and enlists all their primary and less important projects. It presents product’s description and descriptive MoA for major pipeline products alongside each product’s development background and key milestones, gives details about out-licensed and partnered product portfolio, casts light on the latest deals and news, etc.

NAL Pharmaceuticals Ltd. - Product Pipeline Review – 2014. The research publication provides the firm’s description, important data, facts and information. It contains deep analysis of the key pharmaceuticals products, projects, developments and milestones. Furthermore, the study includes NAL Pharmaceuticals Ltd.’s human therapeutic division description. The research covers the company’s major subsidiaries and locations. A in-depth review of the latest news, press releases and updates is given …

More topical research studies by the publisher can be found at Global Markets Direct page.

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected] 
MarketPublishers.com